Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

A flaxseed heteropolysaccharide stimulates immune responses and inhibits hepatitis B virus.

Liang S, Li X, Ma X, Li A, Wang Y, Reaney MJT, Shim YY.

Int J Biol Macromol. 2019 Jun 12. pii: S0141-8130(19)31280-2. doi: 10.1016/j.ijbiomac.2019.06.076. [Epub ahead of print]

PMID:
31201916
2.

Yellow Mealworm Larvae (Tenebrio molitor) Fed Mycotoxin-Contaminated Wheat-A Possible Safe, Sustainable Protein Source for Animal Feed?

Ochoa Sanabria C, Hogan N, Madder K, Gillott C, Blakley B, Reaney M, Beattie A, Buchanan F.

Toxins (Basel). 2019 May 21;11(5). pii: E282. doi: 10.3390/toxins11050282.

3.

Process utilities for topical treatment in atopic dermatitis.

Retzler J, Smith A, Reaney M, Rout R, Hudson R.

Qual Life Res. 2019 Apr 3. doi: 10.1007/s11136-019-02174-0. [Epub ahead of print]

PMID:
30945132
4.

Xylose rich heteroglycan from flaxseed gum mediates the immunostimulatory effects on macrophages via TLR2 activation.

Liu J, Wu C, Li X, Yan Q, Reaney MJT, Jiang Z.

Carbohydr Polym. 2019 Jun 1;213:59-69. doi: 10.1016/j.carbpol.2019.02.080. Epub 2019 Feb 23.

PMID:
30879690
5.

Effects of Sarilumab on Patient-Reported Impact of Rheumatoid Arthritis Using the Rheumatoid Arthritis Impact of Disease Scale.

Gossec L, Strand V, Proudfoot C, Chen CI, Guillonneau S, Kimura T, van Hoogstraten H, Mangan E, Reaney M.

J Rheumatol. 2019 Mar 15. pii: jrheum.180904. doi: 10.3899/jrheum.180904. [Epub ahead of print]

6.

Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.

Yosipovitch G, Reaney M, Mastey V, Eckert L, Abbé A, Nelson L, Clark M, Williams N, Chen Z, Ardeleanu M, Akinlade B, Graham NMH, Pirozzi G, Staudinger H, Plaum S, Radin A, Gadkari A.

Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17744. [Epub ahead of print]

PMID:
30729499
7.

Assessment of gelation behaviour of fenugreek gum and other galactomannans by dynamic viscoelasticity, fractal analysis and temperature cycle.

Gadkari PV, Reaney MJT, Ghosh S.

Int J Biol Macromol. 2019 Apr 1;126:337-344. doi: 10.1016/j.ijbiomac.2018.12.132. Epub 2018 Dec 17.

PMID:
30572043
8.

The Potential Role of Individual-Level Benefit-Risk Assessment in Treatment Decision Making: A DIA Study Endpoints Community Workstream.

Reaney M, Bush E, New M, Paty J, Roborel de Climens A, Skovlund SE, Nelsen L, Flood E, Gater A.

Ther Innov Regul Sci. 2018 Oct 22:2168479018807448. doi: 10.1177/2168479018807448. [Epub ahead of print]

PMID:
30348019
9.

Creating a personalized evaluation framework for patient-reported outcomes: an illustration using the EQ-5D visual analogue scale.

Reaney M, Stassek L, Martin M, McCarrier K, Slagle A, Shields A, Gwaltney CJ.

Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):97-104. doi: 10.1080/14737167.2019.1519398. Epub 2018 Sep 6.

PMID:
30185076
10.

Rheological characterization of fenugreek gum and comparison with other galactomannans.

Gadkari PV, Tu S, Chiyarda K, Reaney MJT, Ghosh S.

Int J Biol Macromol. 2018 Nov;119:486-495. doi: 10.1016/j.ijbiomac.2018.07.108. Epub 2018 Jul 18.

PMID:
30031082
11.

Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.

Strand V, Gossec L, Proudfoot CWJ, Chen CI, Reaney M, Guillonneau S, Kimura T, van Adelsberg J, Lin Y, Mangan EK, van Hoogstraten H, Burmester GR.

Arthritis Res Ther. 2018 Jun 19;20(1):129. doi: 10.1186/s13075-018-1614-z.

12.

Foot care, 'spousal' support and type 2 diabetes: an exploratory qualitative study.

Reaney M, Chmiel N, Churchill S.

Psychol Health. 2018 Sep;33(9):1191-1207. doi: 10.1080/08870446.2018.1481215. Epub 2018 Jun 1.

PMID:
29857779
13.

Novel flax orbitide derived from genetic deletion.

Burnett PG, Young LW, Olivia CM, Jadhav PD, Okinyo-Owiti DP, Reaney MJT.

BMC Plant Biol. 2018 May 21;18(1):90. doi: 10.1186/s12870-018-1303-8.

14.

Novel Flaxseed Gum Nanocomposites Are Slow Release Iron Supplements.

Liang S, Huang Y, Shim YY, Ma X, Reaney MJT, Wang Y.

J Agric Food Chem. 2018 May 23;66(20):5167-5177. doi: 10.1021/acs.jafc.8b01347. Epub 2018 May 15.

PMID:
29737167
15.

Composition and Properties of Aquafaba: Water Recovered from Commercially Canned Chickpeas.

Shim YY, Mustafa R, Shen J, Ratanapariyanuch K, Reaney MJT.

J Vis Exp. 2018 Feb 10;(132). doi: 10.3791/56305.

PMID:
29553544
16.

Development and content validation of a patient-reported endometriosis pain daily diary.

van Nooten FE, Cline J, Elash CA, Paty J, Reaney M.

Health Qual Life Outcomes. 2018 Jan 4;16(1):3. doi: 10.1186/s12955-017-0819-1.

17.

Using Individual Experiences With Experimental Medications to Predict Medication-Taking Behavior Postauthorization: A DIA Study Endpoints Workstream.

Reaney M, McHorney CA, Curtis B, Rydén A, Chassany O, Gwaltney C.

Ther Innov Regul Sci. 2017 Jul;51(4):404-415. doi: 10.1177/2168479017701979. Epub 2017 Apr 4.

PMID:
30227051
18.

Production of Protein Concentrate and 1,3-Propanediol by Wheat-Based Thin Stillage Fermentation.

Ratanapariyanuch K, Shim YY, Emami S, Reaney MJT.

J Agric Food Chem. 2017 May 17;65(19):3858-3867. doi: 10.1021/acs.jafc.7b00772. Epub 2017 May 5.

PMID:
28453269
19.

Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors.

Strand V, Reaney M, Chen CI, Proudfoot CW, Guillonneau S, Bauer D, Mangan E, Graham NM, van Hoogstraten H, Lin Y, Pacheco-Tena C, Fleischmann R.

RMD Open. 2017 Mar 7;3(1):e000416. doi: 10.1136/rmdopen-2016-000416. eCollection 2017.

20.

Secoisolariciresinol Diglucoside and Cyanogenic Glycosides in Gluten-free Bread Fortified with Flaxseed Meal.

Shim YY, Olivia CM, Liu J, Boonen R, Shen J, Reaney MJ.

J Agric Food Chem. 2016 Dec 21;64(50):9551-9558. doi: 10.1021/acs.jafc.6b03962. Epub 2016 Dec 8.

PMID:
27998066
21.

Protein Concentrate Production from Thin Stillage.

Ratanapariyanuch K, Shim YY, Emami S, Reaney MJ.

J Agric Food Chem. 2016 Dec 21;64(50):9488-9496. doi: 10.1021/acs.jafc.6b03816. Epub 2016 Dec 12.

PMID:
27936699
22.

Synthesis and Characterization of Site-Selective Orbitide-BSA Conjugate to Produce Antibodies.

Jadhav PD, Shim YY, Reaney MJ.

Bioconjug Chem. 2016 Oct 19;27(10):2346-2358. Epub 2016 Sep 29.

PMID:
27626291
23.

Conversion of Thin Stillage Compounds Using Endemic Bacteria Augmented with Lactobacillus panis PM1B.

Ratanapariyanuch K, Shim YY, Reaney MJT.

J Agric Food Chem. 2016 Oct 26;64(42):7940-7948. doi: 10.1021/acs.jafc.6b00643. Epub 2016 Oct 18.

PMID:
27696845
24.

Symptoms and Functional Limitations in the First Year Following a Myocardial Infarction: A Qualitative Study.

Gwaltney C, Reaney M, Krohe M, Martin MM, Falvey H, Mollon P.

Patient. 2017 Apr;10(2):225-235. doi: 10.1007/s40271-016-0194-8.

PMID:
27637486
25.

Nomenclature of homodetic cyclic peptides produced from ribosomal precursors: An IUPAC task group interim report.

Craik DJ, Young Shim Y, Göransson U, Moss GP, Tan N, Jadhav PD, Shen J, Reaney MJ.

Biopolymers. 2016 Nov;106(6):917-924. doi: 10.1002/bip.22939.

PMID:
27554762
26.

Well, I Wouldn't be Any Worse Off, Would I, Than I am Now? A Qualitative Study of Decision-Making, Hopes, and Realities of Adults With Type 1 Diabetes Undergoing Islet Cell Transplantation.

Speight J, Woodcock AJ, Reaney MD, Amiel SA, Johnson P, Parrott N, Rutter MK, Senior P, Shaw JA.

Transplant Direct. 2016 Apr 21;2(5):e72. doi: 10.1097/TXD.0000000000000581. eCollection 2016 May.

27.

Reliability and validity of the Psoriasis Itch Visual Analog Scale in psoriasis vulgaris.

Pedersen CB, McHorney CA, Larsen LS, Lophaven KW, Moeller AH, Reaney M.

J Dermatolog Treat. 2017 May;28(3):213-220. doi: 10.1080/09546634.2016.1215405. Epub 2016 Sep 5.

PMID:
27454156
28.

Patient Reported Outcomes (PROs) used in recent Phase 3 trials for Type 2 Diabetes: A review of concepts assessed by these PROs and factors to consider when choosing a PRO for future trials.

Reaney M, Elash CA, Litcher-Kelly L.

Diabetes Res Clin Pract. 2016 Jun;116:54-67. doi: 10.1016/j.diabres.2016.04.009. Epub 2016 Apr 23. Review.

PMID:
27321317
29.

Orbitide Composition of the Flax Core Collection (FCC).

Burnett PG, Olivia CM, Okinyo-Owiti DP, Reaney MJ.

J Agric Food Chem. 2016 Jun 29;64(25):5197-206. doi: 10.1021/acs.jafc.6b02035. Epub 2016 Jun 17.

PMID:
27256931
30.

Vaccenic acid suppresses intestinal inflammation by increasing anandamide and related N-acylethanolamines in the JCR:LA-cp rat.

Jacome-Sosa M, Vacca C, Mangat R, Diane A, Nelson RC, Reaney MJ, Shen J, Curtis JM, Vine DF, Field CJ, Igarashi M, Piomelli D, Banni S, Proctor SD.

J Lipid Res. 2016 Apr;57(4):638-49. doi: 10.1194/jlr.M066308. Epub 2016 Feb 17.

31.

A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes.

Matza LS, Boye KS, Stewart KD, Curtis BH, Reaney M, Landrian AS.

Health Qual Life Outcomes. 2015 Dec 1;13:192. doi: 10.1186/s12955-015-0373-7.

32.
33.

The Conceptual Framework and Content Validity of the Polycystic Ovary Syndrome Patient Reported Outcome (Pcos-Pro) Scale.

Reaney M, Paty J, Black P, Celeste Elash CA, Martin ML, Eek D.

Value Health. 2015 Nov;18(7):A742. doi: 10.1016/j.jval.2015.09.2856. Epub 2015 Oct 20. No abstract available.

34.

Review of Adherence Measures for use in Phase Iv Studies and Recommendations for a new Standardized Generic Measure.

McHorney C, Reaney M.

Value Health. 2015 Nov;18(7):A737. doi: 10.1016/j.jval.2015.09.2825. Epub 2015 Oct 20. No abstract available.

35.

A Comprehensive Disease Model of Polycystic Ovary Syndrome (Pcos).

Eek D, Paty J, Black P, Celeste Elash CA, Reaney M.

Value Health. 2015 Nov;18(7):A722. doi: 10.1016/j.jval.2015.09.2739. Epub 2015 Oct 20. No abstract available.

36.

Patient Reported Outcomes in the Development of new Medications for Type 2 Diabetes: a Review of Recently Approved Products.

Reaney M, Celeste Elash CA.

Value Health. 2015 Nov;18(7):A715. doi: 10.1016/j.jval.2015.09.2701. Epub 2015 Oct 20. No abstract available.

37.

Site Covalent Modification of Methionyl Peptides for the Production of FRET Complexes.

Jadhav PD, Shen J, Sammynaiken R, Reaney MJ.

Chemistry. 2015 Nov 16;21(47):17023-34. doi: 10.1002/chem.201502699. Epub 2015 Oct 5.

PMID:
26434760
38.

Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?

Schloot NC, Haupt A, Schütt M, Badenhoop K, Laimer M, Nicolay C, Reaney M, Fink K, Holl RW.

Diabetes Metab Res Rev. 2016 Mar;32(3):316-24. doi: 10.1002/dmrr.2722. Epub 2015 Nov 20.

PMID:
26409039
39.

Evaluating the cytotoxicity of flaxseed orbitides for potential cancer treatment.

Okinyo-Owiti DP, Dong Q, Ling B, Jadhav PD, Bauer R, Maley JM, Reaney MJT, Yang J, Sammynaiken R.

Toxicol Rep. 2015 Jul 13;2:1014-1018. doi: 10.1016/j.toxrep.2015.06.011. eCollection 2015.

40.

Treatment satisfaction in people with type 2 diabetes mellitus treated with once-weekly dulaglutide: data from the AWARD-1 and AWARD-3 clinical trials.

Reaney M, Yu M, Lakshmanan M, Pechtner V, van Brunt K.

Diabetes Obes Metab. 2015 Sep;17(9):896-903. doi: 10.1111/dom.12527. Epub 2015 Jul 27.

PMID:
26095190
41.

Proposed systematic nomenclature for orbitides.

Shim YY, Young LW, Arnison PG, Gilding E, Reaney MJ.

J Nat Prod. 2015 Apr 24;78(4):645-52. doi: 10.1021/np500802p. Epub 2015 Mar 18.

PMID:
25785712
42.

Glycine-containing flaxseed orbitides.

Burnett PG, Jadhav PD, Okinyo-Owiti DP, Poth AG, Reaney MJ.

J Nat Prod. 2015 Apr 24;78(4):681-8. doi: 10.1021/np5008558. Epub 2015 Mar 17.

PMID:
25781981
43.

A systematic method for selecting patient-reported outcome measures in diabetes research.

Reaney M, Black P, Gwaltney C.

Diabetes Spectr. 2014 Nov;27(4):229-32. doi: 10.2337/diaspect.27.4.229. No abstract available.

44.

Kinetic Interactions between Cyclolinopeptides and Immobilized Human Serum Albumin by Surface Plasmon Resonance.

Shim YY, Reaney MJT.

J Agric Food Chem. 2015 Feb 4;63(4):1099-1106. doi: 10.1021/jf504811x. Epub 2015 Jan 20.

PMID:
25554104
45.

Glucagon-like Peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six European countries.

Divino V, DeKoven M, Hallinan S, Varol N, Wirta SB, Lee WC, Reaney M.

Diabetes Ther. 2014 Dec;5(2):499-520. doi: 10.1007/s13300-014-0087-6. Epub 2014 Nov 4.

46.

Impact of the «Conversation Map™» tools on understanding of diabetes by Spanish patients with type 2 diabetes mellitus: a randomized, comparative study.

Penalba M, Moreno L, Cobo A, Reviriego J, Rodríguez A, Cleall S, Reaney M.

Endocrinol Nutr. 2014 Dec;61(10):505-15. doi: 10.1016/j.endonu.2014.06.001. Epub 2014 Jul 30. English, Spanish.

PMID:
25085598
47.

Simulated moving bed purification of flaxseed oil orbitides: unprecedented separation of cyclolinopeptides C and E.

Okinyo-Owiti DP, Burnett PG, Reaney MJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Aug 15;965:231-7. doi: 10.1016/j.jchromb.2014.06.037. Epub 2014 Jul 8.

PMID:
25049212
48.

Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.

Diamant M, Nauck MA, Shaginian R, Malone JK, Cleall S, Reaney M, de Vries D, Hoogwerf BJ, MacConell L, Wolffenbuttel BH; 4B Study Group.

Diabetes Care. 2014 Oct;37(10):2763-73. doi: 10.2337/dc14-0876. Epub 2014 Jul 10.

PMID:
25011946
49.

The importance of understanding the impact of preference in clinical trials of diabetes interventions.

Reaney M.

J Diabetes. 2014 Nov;6(6):496-8. doi: 10.1111/1753-0407.12187. Epub 2014 Aug 7. No abstract available.

PMID:
24981516
50.

Early discontinuation and restart of insulin in the treatment of type 2 diabetes mellitus.

Ascher-Svanum H, Lage MJ, Perez-Nieves M, Reaney MD, Lorraine J, Rodriguez A, Treglia M.

Diabetes Ther. 2014 Jun;5(1):225-42. doi: 10.1007/s13300-014-0065-z. Epub 2014 Apr 30.

Supplemental Content

Loading ...
Support Center